The Top 5: November 2018
CTA highlights the best articles from the month of November 2018
Trending menu:
-
![]()
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
-
![]()
The Ongoing Fight Against Diabetes
-
![]()
How to Conduct a Diabetes Trial – Lessons Learned
-
![]()
Surveying the Challenges of Preclinical Development
-
![]()
Industry Viewpoints: The Continual Rise of Direct-to-Patient
-
![]()
The Date Is 10/10 – But Is Your Mental Health?
Most Read
- Industry Viewpoints: The Continual Rise of Direct-to-Patient
- Clear Clinical Trial Information is the Key to Patient Engagement
- The Top 5: July 2018
- Pharmacovigilance and Post-Marketing Trials: Stavudine’s Last Fight – Part III
- Pharmacovigilance and Post-Marketing Trials: Stavudine’s Last Fight – Part II
Latest Content
The Top 5: November 2018
CTA highlights the best articles from the month of November 2018
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
Rose Joachim, PhD, Immunology Analyst, GlobalData, examines the impact of newly approved biosimilars on AbbVie’s Humira
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the impact it has on families
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws conclusions
Surveying the Challenges of Preclinical Development
CTA’s Adeola Coker delves into the key issues facing preclinical trials ahead of Arena International’s upcoming Preclinical Development Operations Summit in November
Industry Viewpoints: The Continual Rise of Direct-to-Patient
Michael Sparozic, Lead Trial Supply Operations Manager, Sanofi, address the merits of direct-to-patient shipping to CTA’s Jisong Seo
The Date Is 10/10 – But Is Your Mental Health?
On Mental Health Day, CTA’s Harry Parsons draws attention to mental health awareness
Expert Insights: Will the UK Relax Its Current Regulations for Cannabis-Based Product
Patrick Aiyes, MEng, Immunology Analyst, GlobalData, examines whether the UK is changing its perception on the role of cannabis-based treatments in clinical trials
Clear Clinical Trial Information is the Key to Patient Engagement
Deborah Collyar, Patient Advocates in Research (PAIR) and Catina O’Leary, Health Literacy Media, show why public study summaries need more than plain language to be effective
The 7 Deadly Sins of Audits and Inspections
Stuart Halasz, Associate Director, Clinical Quality Management, Merck & Co., Inc., focuses on “7 Deadly Sins” in Audits and Inspections – and thoughts on reducing their occurrence
Latest News
Go Top
